Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Innovating the Innovation Process. Draetta of IACS has found many of the same issues arise in pharmaceutical research. The Era of Big Science. “But here, we can operate within the time frame of the next coffee break.”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

SEPTEMBER 5, 2013

We detail this process in our HBR article, " Make Time for the Work That Matters."). In 2011, Thierry Andretta, the CEO of French fashion company Lanvin, announced an initiative called "no email Wednesdays" because he thought people had stopped actually talking to each other.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

JUNE 29, 2015

This is consistent with a 2011 article in the Journal of Finance, which also found that “patents of private equity-backed firms applied for in the years after the investment are more frequently cited.” All of this adds to the contentious debate over whether PE investors sacrifice long-term growth for short-term profit.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

OCTOBER 3, 2013

Back in 2011, in Citrus Lane’s first six months, its small founding team worked in a house and ate lunch together every day around a big table. Today that kind of marketplace scaling often means a more complicated process of global expansion– such as IKEA’s opening stores in China, or Home Depot’s failed efforts to do so.

Pharmaceuticals 8

Pharmaceuticals Seminar Learning-by-Doing Open-book 8

Harvard Business Review

MAY 17, 2012

In 2011, Embrace piloted the product in India, where 1.2 For us, innovation is a dynamic process that never ends.''. Embrace has already negotiated partnerships with multinational pharmaceutical and medical device companies such as GE Healthcare. million premature babies die each year. Early results have been very encouraging.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Strategy Driven

JANUARY 24, 2011

That said, yet another change management process or program is not the solution. And our research, as well as the research of others, indicates that successful change is connected more to the individual and collective mindsets of employees than any process. It’s an ongoing process. Change is made one person at a time.

Execution 68

Execution Company 360-Degree Feedback Cooper 68

Harvard Business Review

NOVEMBER 20, 2015

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MARCH 4, 2011

And that should make it easier for IBM to sell the question-answering technology in hospitals, law firms, pharmaceutical labs, call centers, and every other area in which people are grappling with finding answers in ever larger sets of data. This kind of defensive analysis no doubt provided some comfort to the public.

Learning Curve 11

Learning Curve Pharmaceuticals Call Center Technology 11

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. The answer is that no one succeeded at duplicating the extraction process, which Wyeth had not patented, but rather kept as a trade secret. The key ingredient in Premarin is conjugated estrogens extracted from pregnant mare urine. That’s right.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 11, 2014

Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. In our new book, The Innovator’s Method , we show how managers can adapt these tools, in an end-to-end process, for managing innovation.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MAY 25, 2017

According to QuintilesIMS , there are more than 2,000 drugs in the late-stage approval process, and they will yield an estimated 45 new active substances annually over the next five years. In 2011 81 digital health startups received venture funding; with consistent year-over-year increases, 296 startups were venture backed in 2016.

Health Care 9

Health Care Trends Venture Funding Technology 9